| Health / Medical Topics |
Yttrium Y 90-DOTA monoclonal antibody HuPAM4
Pronunciation
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 contains a monoclonal antibody that binds to a protein called MUC-1, which is found on some pancreatic cancer cells. It also contains a radioactive substance called yttrium Y 90, which may help kill cancer cells. Yttrium Y 90-DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate. Also called yttrium Y 90-clivatuzumab tetraxetan. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance being studied in the treatment of liver cancer. HuAFP31 is a monoclonal antibody that can bind to tumor cells that…
A substance being studied in the treatment of some types of cancer. M5A is a monoclonal antibody that binds to a protein…
A substance being studied in the treatment of advanced pancreatic cancer. Yttrium Y 90-clivatuzumab tetraxetan contains a monoclonal antibody that binds to…
A substance being studied in the treatment of some types of cancer. Yttrium Y 90 SMT 487 contains a molecule that binds…
An injectable formulation of the radioisotope yttrium Y 90 encapsulated in resin microspheres with potential antineoplastic activity. When injected into arterial vasculature…
A radioimmunotherapeutic monoclonal antibody (MN-14) directed against tumor-associated carcinoembryonic antigen (CEA) and chelated to the radioisotope yttrium-90 (Y 90). Yttrium 90 monoclonal…
